Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd

₹ 61.4 -2.11%
21 May - close price
About

Incorporated in 1985, Sandu Pharmaceuticals Ltd manufactures and trades Ayurvedic proprietary medicines.

Key Points

Product Portfolio:[1]
Company manufactures over 100 types of products, including oils, syrups, granules, powder, and avlehas, which are marketed under the Sandu brand viz, Sandu Ashoka Compound, Sandu Abhayarishta, Sandu Arvindasav, Sandu Balant Kadha No. 1, Sandu Debix Tablet, Sandu Bhunimbadi Kadha, Sandu Chandanasav Syrup, Sandu Chandraprabha, Sandu Chyavanprash Special, Sandu Dadimavaleha, etc.

  • Market Cap 59.3 Cr.
  • Current Price 61.4
  • High / Low 85.0 / 49.0
  • Stock P/E 52.0
  • Book Value 41.7
  • Dividend Yield 1.22 %
  • ROCE %
  • ROE 4.02 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
17.59 19.15 11.42 16.23 16.76 17.09 15.26 17.66 16.61 17.43
16.79 18.38 10.85 15.91 15.90 16.27 14.77 17.31 15.79 16.92
Operating Profit 0.80 0.77 0.57 0.32 0.86 0.82 0.49 0.35 0.82 0.51
OPM % 4.55% 4.02% 4.99% 1.97% 5.13% 4.80% 3.21% 1.98% 4.94% 2.93%
0.03 0.00 0.03 0.09 0.17 0.03 0.04 0.00 0.09 0.03
Interest 0.05 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02
Depreciation 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.12 0.13 0.14
Profit before tax 0.65 0.64 0.45 0.26 0.88 0.70 0.38 0.21 0.77 0.38
Tax % 30.77% 29.69% 40.00% 34.62% 31.82% 30.00% 26.32% 47.62% 27.27% 44.74%
0.45 0.45 0.27 0.17 0.60 0.48 0.27 0.11 0.55 0.21
EPS in Rs 0.57 0.57 0.31 0.19 0.62 0.50 0.28 0.11 0.57 0.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 TTM
65.50 65.35 66.96
62.62 62.87 64.79
Operating Profit 2.88 2.48 2.17
OPM % 4.40% 3.79% 3.24%
0.08 0.33 0.16
Interest 0.11 0.08 0.07
Depreciation 0.53 0.52 0.52
Profit before tax 2.32 2.21 1.74
Tax % 31.47% 31.22%
1.59 1.52 1.14
EPS in Rs 1.80 1.57 1.18
Dividend Payout % 41.56% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -25%
Stock Price CAGR
10 Years: 20%
5 Years: 24%
3 Years: 15%
1 Year: 8%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Sep 2023
Equity Capital 8.81 9.66 9.66
Reserves 27.66 29.58 30.60
0.00 0.00 0.00
12.81 14.93 12.66
Total Liabilities 49.28 54.17 52.92
16.00 16.62 16.72
CWIP 0.48 0.42 0.67
Investments 9.11 9.65 10.03
23.69 27.48 25.50
Total Assets 49.28 54.17 52.92

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
0.95 0.22
-5.47 0.54
0.93 0.58
Net Cash Flow -3.59 1.34

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
Debtor Days 22.23 26.75
Inventory Days 115.06 167.70
Days Payable 69.63 98.30
Cash Conversion Cycle 67.67 96.15
Working Capital Days 42.41 52.33
ROCE %

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
45.04% 45.04% 48.02% 50.43% 50.43% 50.43% 50.43% 52.42% 52.42% 42.91% 42.91% 42.91%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
54.95% 54.95% 51.97% 49.56% 49.56% 49.56% 49.55% 47.59% 47.58% 57.10% 57.10% 57.09%
No. of Shareholders 10,10810,50810,37410,38610,32010,22810,26410,14110,12110,10310,02110,001

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents